Impacts of the One Big Beautiful Bill Act on the Agriculture and Food Industry
Tariffs and Trade Series: Effects on Agriculture Operations and Markets
First 60 Days of the Trump Administration: Food and Agriculture Policy
4 Key Takeaways | AI in Precision Agriculture Legal Risks and Mitigation
Insights on the Trump Administration's Agriculture and Food Policy Priorities
GLP-1 Drugs and Cultivated Meat: What’s the Impact on the Food and Agriculture Industry?
Florida’s Equine Landscape
Stoel Rives | Deeply Rooted Podcast S3E3: AgTech Innovation and Robotics with Burro CEO Charlie Andersen
[Podcast] Keith Matthews and Chris Wozniak: Talking Ag Biotech Episode 5
Exploring ESG in the Food, Beverage and Agribusiness Sectors
How Technology Has Transformed Today’s Agriculture Commodities Market
[Podcast] Keith Matthews and Chris Wozniak: Talking Ag Biotech Episode 2
[Podcast] Keith Matthews and Chris Wozniak: Talking Ag Biotech
[Podcast] Cellular Agriculture and the Evolving Legal/Regulatory Landscape: A Conversation with Ahmed Khan
Regenerative Agriculture: A Sustainable ESG Strategy
Stoel Rives | Deeply Rooted Podcast Episode Six: Understanding the Intersection of ESG and the Forest Sector with MaryKate Bullen, Director of Sustainability and ESG of Forest Investment Associates
Stoel Rives | Deeply Rooted Podcast Episode Five: Exploring Succession and Generational Change with Kevin Adams, Managing Director for The Mountain Group
Stoel Rives | Deeply Rooted Podcast Episode Four: The Financialization of Agriculture with David Muth from Alternative Equity Advisors
Stoel Rives | Deeply Rooted Podcast Episode Three: Diversity in Agriculture: From its People to its Products with Elin Miller, Founder of Umpqua Nut Farms & Umpqua Vineyards
Stoel Rives | Deeply Rooted Podcast Episode Two: A Bright Future for Agriculture with Phil Ward, CEO of Oregon Future Farmers of America
On May 22, 2025, President Trump’s Make America Healthy Again (MAHA) Commission released an assessment titled “The MAHA Report: Make Our Children Healthy Again Assessment.” The report—framed as a “call to action”—stems from a...more
FDA approves three color additives derived from natural sources. In order to “expand the palette of available colors from natural sources for manufacturers to safely use in food,” the FDA announced on May 9 that it has...more
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal, and regulatory landscape. Jim Jones, Deputy Commissioner for Human Foods at the US Food and Drug...more
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal, and regulatory landscape....more
Intentional genomic alterations (IGAs) in animals refer to deliberate changes made to the genetic material of animals. These alterations are designed to introduce, remove or modify specific traits in animals for various...more
Leaders of Small Business Committee Reach Consensus on Bill to Extend PPP Loan Deadline, Senate Fails to Clear Measure by Unanimous Consent as Phase 4 Negotiations Likely to Dominate June - Bipartisan leaders of the Senate...more
In response to concerns expressed by livestock groups and some in the biotechnology industry over the Food and Drug Administration's (FDA's) approval process for gene editing in animals, the Trump administration issued an...more
Silverman Speaks to Congressional Staff About Food Litigation Trends - Shook Partner Cary Silverman was an invited panelist at The George Mason University Antonin Scalia Law School’s Law and Economics Center’s...more
Agency Notice Touts Authority to Regulate Products Containing Cannabis and Cannabis-derived Compounds - On April 4, 2019, the U.S. Food and Drug Administration (FDA) published a notice in the Federal Register that it...more
While the legal landscape continues to evolve in the cannabis industry, making entry into the space a potentially risky proposition, the passage of the Agriculture Improvement Act of 2018 (the “Farm Bill”) can be a real game...more
FDA Seeks Comment on Regulation Changes for "Meaningful Burden Reduction" - Implementing an executive order titled "Reducing Regulation and Controlling Regulatory Costs," the U.S. Food and Drug Administration (FDA) has...more